palbociclib
pfizer
['congrat', 'palbociclib', 'sarcoma']
palbosarc (geis-51) results presented at #asco2022.
higher levels of cdk4 correlated with better outcomes with palbociclib in advanced sts, excluding liposarcoma.
congrats dr martin for another asco presentation, representing again 
twitter oficial del Grupo Español de Investigación en Sarcomas